I agree that this site is using cookies. You can find further informations here.
X
FUKAI, Junya
114  results:
Search for persons X
?
1

Prediction of MGMT promotor methylation status in glioblast..:

Sanada, Takahiro ; Kinoshita, Manabu ; Sasaki, Takahiro...
Neuro-Oncology Advances.  6 (2024)  1 - p. , 2024
Link: https://doi.org/10.1093/..
 
?
2

Extremely slow-growing cerebellar ganglioglioma in an elder..:

Ohtani, Nao ; Sasaki, Takahiro ; Yamoto, Toshikazu...
Surgical Neurology International.  15 (2024)  - p. 33 , 2024
Link: https://doi.org/10.25259..
 
?
3

Neuroradiological, genetic and clinical characteristics of ..:

Hayashi, Nobuhide ; Fukai, Junya ; Nakatogawa, Hirokazu...
Acta Neuropathologica Communications.  12 (2024)  1 - p. , 2024
Link: https://doi.org/10.1186/..
 
?
4

RARE-03. GENOME-WIDE ASSOCIATION STUDY OF INTRACRANIAL GERM..:

Terashima, Keita ; Sonehara, Kyuto ; Kimura, Yui...
Neuro-Oncology.  25 (2023)  Supplement_1 - p. i33-i34 , 2023
Link: https://doi.org/10.1093/..
 
?
5

10184-BT-14 CLINICAL FEATURE OF HEMISPHERIC GLIOMA WITH H3F..:

Nakatogawa, Hirokazu ; Kawaji, Hiroshi ; Hayashi, Nobuhide...
Neuro-Oncology Advances.  5 (2023)  Supplement_5 - p. v18-v19 , 2023
Link: https://doi.org/10.1093/..
 
?
6

Reciprocal expression of the immune response genes CXCR3 an..:

Takashima, Yasuo ; Hamano, Momoko ; Yoshii, Kengo...
International Journal of Clinical Oncology.  28 (2023)  3 - p. 468-481 , 2023
Link: https://doi.org/10.1007/..
 
?
7

10179-NI-8 CLINICORADIOLOGICAL CHARACTERISTICS OF H3 K27-AL..:

Hayashi, Nobuhide ; Fukai, Junya ; Nakatogawa, Hirokazu...
Neuro-Oncology Advances.  5 (2023)  Supplement_5 - p. v18-v18 , 2023
Link: https://doi.org/10.1093/..
 
?
8

10020-ML-1 SENTINEL LESION PRECEDING PRIMARY CENTRAL NERVOU..:

Sasaki, Takahiro ; Yamoto, Toshikazu ; Fukai, Junya..
Neuro-Oncology Advances.  5 (2023)  Supplement_5 - p. v3-v3 , 2023
Link: https://doi.org/10.1093/..
 
?
9

10015-NI-1 PREDICTION OF MGMT PROMOTOR METHYLATION STATUS I..:

Sanada, Takahiro ; Kinoshita, Manabu ; Sasaki, Takahiro...
Neuro-Oncology Advances.  5 (2023)  Supplement_5 - p. v3-v3 , 2023
Link: https://doi.org/10.1093/..
 
?
10

10025-MPC-3 DIFFERENCE AMONG GENERATIONS IN PATIENTS WITH H..:

Fukai, Junya ; Hayashi, Nobuhide ; Nakatogawa, Hirokazu...
Neuro-Oncology Advances.  5 (2023)  Supplement_5 - p. v4-v4 , 2023
Link: https://doi.org/10.1093/..
 
?
11

MPC-15 CLINICAL FEATURE OF NON-MIDLINE GLIOMA WITH H3F3A GE..:

Nakatogawa, Hirokazu ; Kawaji, Hiroshi ; Hayashi, Nobuhide...
Neuro-Oncology Advances.  4 (2022)  Supplement_3 - p. iii15-iii15 , 2022
Link: https://doi.org/10.1093/..
 
?
12

A common deletion at BAK1 reduces enhancer activity and con..:

Sonehara, Kyuto ; Kimura, Yui ; Nakano, Yoshiko...
Nature Communications.  13 (2022)  1 - p. , 2022
Link: https://doi.org/10.1038/..
 
?
13

BOT-3 GENOME-WIDE ASSOCIATION STUDY OF INTRACRANIAL GERM CE..:

Terashima, Keita ; Sonehara, Kyuto ; Kimura, Yui...
Neuro-Oncology Advances.  4 (2022)  Supplement_3 - p. iii7-iii7 , 2022
Link: https://doi.org/10.1093/..
 
?
14

MPC-8 CLINICAL CHARACTERISTICS OF H3 K27-MUTATED GLIOMAS AT..:

Hayashi, Nobuhide ; Fukai, Junya ; Nakatogawa, Hirokazu...
Neuro-Oncology Advances.  4 (2022)  Supplement_3 - p. iii15-iii15 , 2022
Link: https://doi.org/10.1093/..
 
?
15

NQPC-9 CHARACTERIZATION AND MANAGEMENT OF DERMATOLOGIC ADVE..:

Fukai, Junya ; Seki, Kohei ; Sasaki, Takahiro..
Neuro-Oncology Advances.  4 (2022)  Supplement_3 - p. iii19-iii19 , 2022
Link: https://doi.org/10.1093/..
 
1-15